Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Colgate-Palmolive is due for a turnaround, one analyst says. Here’s what can drive it.
Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone. However, the company’s revenue guidance came in below Wall Street’s expectations.
Why Colgate-Palmolive Stock Fell Today
Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook. Revenue growth slowed down from earlier in the year as price hikes it had previously implemented rolled off.
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Would you like to be notified of the latest news and updates on the stock market?
Colgate-Palmolive stock analysis: overvalued ahead of earnings
What is the outlook of the Colgate Palmolive stock price ahead of earnings? We explain whether it may drop soon
Is Colgate-Palmolive Company (CL) the Best Diversified Dividend Stock to Buy Now?
We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against the other diversified dividend stocks.
Colgate-Palmolive Q4: EPS Beat, Sales Miss, Cautious FY25 Forecast And More
Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic sales rose by 4.3%, and non-GAAP EPS of $0.91 surpassed the consensus. The company expects flat FY25 sales.
Colgate-Palmolive Sees FY25 Earnings, Organic Sales Growth - Update
While reporting financial results for the fourth quarter on Friday, Colgate-Palmolive Co. (CL) initiated its earnings, adjusted
Colgate-Palmolive: Q4 Earnings Snapshot
The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 89 cents per share. The consumer products maker posted revenue of $4.94 billion in the period, which missed Street forecasts.
Colgate-Palmolive EPS Up, Revenue Lags
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
Colgate Brushes Past Earnings Estimates. It Wasn’t Enough.
Colgate forecasts net sales to be roughly flat, while analysts had penciled in an increase of about 1%. The company expects organic sales growth to be within the 3% to 5
2d
on MSN
Colgate-Palmolive anticipates strong 2025 growth with focus on premiumization and innovation
Q4 2024 Management View CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ...
2d
Colgate-Palmolive Co. Q4 Profit Increases, Beats Estimates
Colgate-Palmolive Co. (CL) revealed earnings for its fourth quarter that increased from the same period last year and beat the ...
2d
Colgate looking to reduce the impact of possible tariffs on toothpaste made in Mexico
Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...
2d
on MSN
Colgate-Palmolive Stock Falls as Foreign Exchange Rates Hurt Sales, Outlook
Colgate-Palmolive shares dropped Friday after the household products company missed revenue forecasts and gave weak guidance as it was hurt by foreign exchange rates.
6d
Colgate-Palmolive (CL) Receives a Buy from Morgan Stanley
Morgan Stanley analyst Dara Mohsenian maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...
Zacks.com on MSN
5d
Colgate Stock Sees Strong Momentum Pre-Q4 Earnings: Time to Invest?
Colgate-Palmolive Company CL is expected to register top and bottom-line growth when it reports its fourth-quarter 2024 ...
4d
Colgate-Palmolive (NYSE:CL) Shares Sold by Geneos Wealth Management Inc.
Geneos Wealth Management Inc. lessened its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 3.3% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback